company background image
BXPHARMA logo

Beximco Pharmaceuticals DSE:BXPHARMA Stock Report

Last Price

৳100.40

Market Cap

৳45.9b

7D

-8.6%

1Y

-31.3%

Updated

11 Jun, 2024

Data

Company Financials +

Beximco Pharmaceuticals Limited

DSE:BXPHARMA Stock Report

Market Cap: ৳45.9b

BXPHARMA Stock Overview

Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.

BXPHARMA fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance5/6
Financial Health6/6
Dividends5/6

Beximco Pharmaceuticals Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Beximco Pharmaceuticals
Historical stock prices
Current Share Price৳100.40
52 Week High৳146.20
52 Week Low৳99.80
Beta0.63
1 Month Change-19.10%
3 Month Change-17.09%
1 Year Change-31.33%
3 Year Change-41.29%
5 Year Change41.95%
Change since IPO638.60%

Recent News & Updates

Recent updates

Shareholder Returns

BXPHARMABD PharmaceuticalsBD Market
7D-8.6%-4.0%-4.0%
1Y-31.3%-25.4%-27.3%

Return vs Industry: BXPHARMA underperformed the BD Pharmaceuticals industry which returned -25% over the past year.

Return vs Market: BXPHARMA underperformed the BD Market which returned -26.8% over the past year.

Price Volatility

Is BXPHARMA's price volatile compared to industry and market?
BXPHARMA volatility
BXPHARMA Average Weekly Movement4.3%
Pharmaceuticals Industry Average Movement6.7%
Market Average Movement5.2%
10% most volatile stocks in BD Market7.7%
10% least volatile stocks in BD Market3.3%

Stable Share Price: BXPHARMA's share price has been volatile over the past 3 months.

Volatility Over Time: BXPHARMA's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1976n/an/awww.beximcopharma.com

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids.

Beximco Pharmaceuticals Limited Fundamentals Summary

How do Beximco Pharmaceuticals's earnings and revenue compare to its market cap?
BXPHARMA fundamental statistics
Market cap৳45.86b
Earnings (TTM)৳5.33b
Revenue (TTM)৳43.08b

8.4x

P/E Ratio

1.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BXPHARMA income statement (TTM)
Revenue৳43.08b
Cost of Revenue৳24.46b
Gross Profit৳18.63b
Other Expenses৳13.30b
Earnings৳5.33b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)11.95
Gross Margin43.24%
Net Profit Margin12.37%
Debt/Equity Ratio13.8%

How did BXPHARMA perform over the long term?

See historical performance and comparison

Dividends

3.5%

Current Dividend Yield

29%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.